180 Life Sciences Corp. (ATNF)
NASDAQ: ATNF · IEX Real-Time Price · USD
2.140
-0.250 (-10.46%)
Jul 19, 2024, 4:00 PM EDT - Market closed
180 Life Sciences Market Cap
180 Life Sciences has a market cap or net worth of $2.02 million as of July 22, 2024. Its market cap has decreased by -64.02% in one year.
Market Cap
2.02M
Enterprise Value
2.13M
1-Year Change
-64.02%
Ranking
Category
Stock Price
$2.14
Market Cap Chart
Since June 27, 2017, 180 Life Sciences's market cap has decreased from $125.60M to $2.02M, a decrease of -98.40%. That is a compound annual growth rate of -44.28%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 2.00M | 25.00% |
| Dec 29, 2023 | 1.60M | -76.81% |
| Dec 30, 2022 | 6.90M | -94.80% |
| Dec 31, 2021 | 132.70M | 169.72% |
| Dec 31, 2020 | 49.20M | -43.64% |
| Dec 31, 2019 | 87.30M | -42.45% |
| Dec 31, 2018 | 151.70M | 4.98% |
| Dec 29, 2017 | 144.50M | 15.05% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phio Pharmaceuticals | 2.30M |
| Tivic Health Systems | 2.17M |
| NovaBay Pharmaceuticals | 2.16M |
| Windtree Therapeutics | 2.14M |
| NanoVibronix | 2.12M |
| Nuwellis | 1.96M |
| Galmed Pharmaceuticals | 1.83M |
| Azitra | 1.76M |